Research map: Risk factors of docetaxel-induced peripheral edema in non-small cell lung cancer treatment: a multi-institutional cohort study

Back to the article

Papers in this map

  1. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries · Freddie Bray · 2024 · 26051 citations · Cited by this paper
  2. End-of-life cancer care quality in rural areas of Japan: an exploratory bereaved family survey · 2026 · Related
  3. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics · Yoshinobu Kanda · 2012 · 19329 citations · Cited by this paper
  4. Developing quality indicators for supportive care in cancer treatment: a modified Delphi method · 2026 · Related
  5. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma · Richard S. Finn · 2020 · 7562 citations · Cited by this paper
  6. Hereditary cancer multigene panel testing in the United States and Europe: real-world constraints and implications for responsible integration in Japan · 2026 · Related
  7. Revised Equations for Estimated GFR From Serum Creatinine in Japan · Seiichi Matsuo · 2009 · 6537 citations · Cited by this paper
  8. A multicenter randomized phase II/III trial of salvage treatment for refractory primary central nervous system lymphoma using tirabrutinib: JCOG2314 (ReSTART) · 2026 · Related
  9. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer · Napoleone Ferrara · 2004 · 2634 citations · Cited by this paper
  10. Resolution of peritoneal metastases in CLDN18.2-positive gastric cancer treated with CAPOX plus zolbetuximab · 2026 · Related
  11. Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer · Sandra M. Swain · 2015 · 2188 citations · Cited by this paper
  12. Reconsidering prostate cancer screening: limitations of net survival and the primacy of overall survival as an endpoint · 2026 · Related
  13. Non-small cell lung cancer: current treatment and future advances · Cecilia Zappa · 2016 · 2044 citations · Cited by this paper
  14. A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY) · 2026 · Related
  15. Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer · Marshall R. Posner · 2007 · 1710 citations · Cited by this paper
  16. Age-standardized mortality-to-incidence ratio for lymphoma in the world · 2026 · Related
  17. Vascular Permeability Factor/Vascular Endothelial Growth Factor Induces Lymphangiogenesis as well as Angiogenesis · Janice A. Nagy · 2002 · 561 citations · Cited by this paper
  18. Clinical utility of tumour markers in skeletal metastasis of unknown primary at the initial visit · 2026 · Related
  19. Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer · Stephen E. Jones · 2005 · 553 citations · Cited by this paper
  20. Influence of pathologic fractures on oncologic outcomes in extremity Ewing sarcoma: a single-institution retrospective study · 2026 · Related
  21. Inhibition of VEGFR-3 Activation with the Antagonistic Antibody More Potently Suppresses Lymph Node and Distant Metastases than Inactivation of VEGFR-2 · Nicole Roberts · 2006 · 315 citations · Cited by this paper
  22. Peripheral edema · Shaun Cho · 2002 · 195 citations · Cited by this paper
  23. Reliability and Feasibility of Methods to Quantitatively Assess Peripheral Edema · K. G. Brodovicz · 2009 · 181 citations · Cited by this paper
  24. The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV · Hiroaki Akamatsu · 2019 · 154 citations · Cited by this paper
  25. Cooperative and redundant roles of VEGFR‐2 and VEGFR‐3 signaling in adult lymphangiogenesis · Jeremy Goldman · 2007 · 148 citations · Cited by this paper
  26. Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC) · R. Gervais · 2004 · 118 citations · Cited by this paper
  27. A randomized, double-blind, phase II study of ramucirumab plus docetaxel vs placebo plus docetaxel in Japanese patients with stage IV non-small cell lung cancer after disease progression on platinum-based therapy · Kiyotaka Yoh · 2016 · 113 citations · Cited by this paper
  28. The pathophysiological mechanism of fluid retention in advanced cancer patients treated with docetaxel, but not receiving corticosteroid comedication · Abraham Behar · 1997 · 75 citations · Cited by this paper
  29. The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition · Mitsuo Terada · 2023 · 65 citations · Cited by this paper
  30. Effects of the taxanes paclitaxel and docetaxel on edema formation and interstitial fluid pressure · Aurora Brønstad · 2004 · 56 citations · Cited by this paper
  31. Ramucirumab: preclinical research and clinical development · Giuseppe Aprile · 2014 · 54 citations · Cited by this paper
  32. Impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: a retrospective study · Kenji Morimoto · 2021 · 50 citations · Cited by this paper
  33. Somatosensory predictors of response to pregabalin in painful chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled, crossover study · Alexander M. Hincker · 2019 · 46 citations · Cited by this paper
  34. Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration · Yuka Aoishi · 2020 · 44 citations · Cited by this paper
  35. Peripheral edema: A common and persistent health problem for older Americans · Soroush Besharat · 2021 · 43 citations · Cited by this paper
  36. Subjective and Objective Assessment of Edema during Adjuvant Chemotherapy for Breast Cancer Using Taxane-Containing Regimens in a Randomized Controlled Trial: The National Surgical Adjuvant Study of Breast Cancer 02 · Shozo Ohsumi · 2012 · 42 citations · Cited by this paper
  37. 2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis · Hirotoshi Iihara · 2024 · 38 citations · Cited by this paper
  38. Relationship of Vascular Endothelial Growth Factor C, a Lymphangiogenesis Modulator, With Edema Formation, Congestion and Outcomes in Acute Heart Failure · Gracjan Iwanek · 2023 · 25 citations · Cited by this paper
  39. Prediction of breast cancer-related lymphedema risk after postoperative radiotherapy via multivariable logistic regression analysis · Jae Sik Kim · 2022 · 20 citations · Cited by this paper

Source: OpenAlex (CC0)